Komori
COSMOS Pharmaceutical (3349) · RiskDropped

Interest-rate risk on borrowings and hedging with interest-rate swaps

First written in FY2017. 1 of 10 entries say "Dropped", first in FY2026. Latest entry: FY2026.

10entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2017 – FY20262017: 12018: 120182019: 120192020: 120202021: 120212022: 120222023: 120232024: 120242025: 120252026: 12026
Same theme, other companies
Interest-Rate Hedging of Long-Term Borrowings Using Interest-Rate SwapsA theme 171 companies write about · 92 as a headwind · 73 as a tailwind

The whole theme swung hardest in 2025: 13 of 59 companies on the "Worse" side.

9 other companies' latest entry also says "Dropped".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 171 companies compared. The sentences above are computed from all 171.
Full recordFilings, disclosures and news, newest first
  1. FY2026DroppedAnnual report

    「Consolidated fiscal year (31 May 2026): Not applicable.」

    The disclosure of the ¥214 million in interest rate swap contracts remaining in the previous fiscal year was removed, and there were no derivatives transactions subject to hedge accounting in the fiscal year.
  2. FY2025Hedging contract balance updatedAnnual report

    「Interest rate swaps Fixed payments, floating receipts Long-term borrowings 214 —」

    The amount of interest rate swap contracts and related items hedging the risk of changes in borrowing rates was updated from ¥916 million in the previous fiscal year to ¥214 million, and the amount with a maturity exceeding 1 year fell to zero.
  3. FY2024Hedging contract balance updatedAnnual report

    「Interest rate swaps Fixed payments, floating receipts Long-term borrowings 916 214」

    The amount of interest rate swap contracts and related items hedging the risk of changes in borrowing rates was updated from ¥1,618 million in the previous fiscal year to ¥916 million.
  4. FY2023Hedging contract balance updatedAnnual report

    「Interest rate swaps Fixed payments, floating receipts Long-term borrowings 1,618 916」

    The amount of interest rate swap contracts and related items hedging the risk of changes in borrowing rates was updated from ¥2,320 million in the previous fiscal year to ¥1,618 million.
  5. FY2022Hedging contract balance updatedAnnual report

    「Interest rate swaps Fixed payments, floating receipts Long-term borrowings 2,320 1,618」

    The amount of interest rate swap contracts and related items hedging the risk of changes in borrowing rates was updated from ¥3,022 million in the previous fiscal year to ¥2,320 million.
  6. FY2021Hedging contract balance updatedAnnual report

    「Interest rate swaps Fixed payments, floating receipts Long-term borrowings 3,022 2,320」

    The amount of interest rate swap contracts and related items hedging the risk of changes in borrowing rates was updated from ¥3,724 million in the previous fiscal year to ¥3,022 million.
  7. FY2020Hedging contract balance updatedAnnual report

    「Interest rate swaps Fixed payments, floating receipts Long-term borrowings 3,724 3,022」

    The amount of interest rate swap contracts and related items hedging the risk of changes in borrowing rates was updated from ¥4,426 million in the previous fiscal year to ¥3,724 million.
  8. FY2019Hedging contract balance updatedAnnual report

    「Fiscal year ended 31 May 2019 Interest rate swaps Fixed payments, floating receipts Long-term borrowings 4,426 3,724」

    The amount of interest rate swap contracts and related items hedging the risk of changes in borrowing rates was updated from ¥5,128 million in the previous fiscal year to ¥4,426 million.
  9. FY2018Hedging contract balance updatedAnnual report

    「Fiscal year ended 31 May 2018 Interest rate swaps Fixed payments, floating receipts Long-term borrowings 5,128 4,426」

    The amount of interest rate swap contracts and related items hedging the risk of changes in borrowing rates was updated from ¥5,830 million in the previous fiscal year to ¥5,128 million.
  10. FY2017First statedAnnual report

    「Derivative transactions consist of interest-rate swaps used to hedge the risk of fluctuations in interest payments on borrowings.」

    The company identifies interest-rate risk on borrowings and uses interest-rate swaps as a hedge. The notional amount and other terms of the swaps for the fiscal year totaled ¥5,830 million.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for COSMOS Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Interest-rate risk on borrowings and hedging with interest-rate swaps | COSMOS Pharmaceutical Corporation (3349) | Komori